Transipeg



Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 37.2%
Product Used For Unknown Indication 24.8%
Constipation 5.3%
Myalgia 5.3%
Musculoskeletal Pain 4.4%
Chronic Obstructive Pulmonary Disease 3.5%
Pain 2.7%
Cholecystitis 1.8%
Cholinergic Syndrome 1.8%
Depression 1.8%
Gastric Ulcer 1.8%
Prophylaxis 1.8%
Sleep Disorder 1.8%
Atrial Fibrillation 0.9%
Cardiac Disorder 0.9%
Cryoglobulinaemia 0.9%
Erythema 0.9%
Hepatitis C 0.9%
Herpes Ophthalmic 0.9%
Hyperphosphataemia 0.9%
Vomiting 23.7%
Pneumomediastinum 10.5%
Urticaria 7.9%
Alanine Aminotransferase Increased 5.3%
Hallucination 5.3%
Hepatitis 5.3%
Renal Failure Acute 5.3%
Suicide Attempt 5.3%
Arrhythmia 2.6%
Aspartate Aminotransferase Increased 2.6%
Chorea 2.6%
Deep Vein Thrombosis 2.6%
Eczema 2.6%
Fall 2.6%
Febrile Neutropenia 2.6%
Gastrointestinal Necrosis 2.6%
Gastrointestinal Sounds Abnormal 2.6%
Hallucination, Visual 2.6%
Jaundice 2.6%
Platelet Count Decreased 2.6%
Concomitant
Product Used For Unknown Indication 31.8%
Drug Use For Unknown Indication 14.3%
Hypertension 6.7%
Constipation 6.6%
Pain 6.1%
Depression 5.2%
Anxiety 4.0%
Epilepsy 3.5%
Pyelonephritis 2.4%
Prophylaxis 2.3%
Multiple Myeloma 2.1%
Thrombosis Prophylaxis 2.1%
Cardiac Failure 1.9%
Hodgkin's Disease 1.9%
Prostate Cancer 1.7%
Essential Hypertension 1.6%
Neuralgia 1.5%
Gastric Cancer 1.4%
Hiv Infection 1.4%
Psychotic Disorder 1.4%
Vomiting 14.7%
Somnolence 9.2%
Overdose 6.7%
Renal Failure 6.7%
Renal Failure Acute 6.1%
Hyponatraemia 5.5%
Malaise 4.9%
Neutropenia 4.3%
Weight Increased 4.3%
Henoch-schonlein Purpura 3.7%
Hypotension 3.7%
Interstitial Lung Disease 3.7%
Leukopenia 3.7%
Thrombocytopenia 3.7%
Tremor 3.7%
Confusional State 3.1%
Drug Interaction 3.1%
Off Label Use 3.1%
Pancytopenia 3.1%
Rhabdomyolysis 3.1%